LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2009

Apr 27, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2009-04-24

Reporting Person: Palantoni Frank (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-04-24	Stock Option (right to buy)	$0.99	A	10000	Acquired	2019-04-24	Common Stock (10000.00)	Direct

Footnotes

F1: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant.